CVS Related Analyst Ratings
-
UBS Starts CVS Caremark (CVS) at Buy, $34 Target
-
Goldman Sachs Makes Its Bullish Case on CVS Caremark (CVS)
-
William Blair Downgrades CVS Caremark (CVS) to Market Perform
-
Goldman Sachs Makes Positive Comments on CVS (CVS) Ahead of Results
-
Deutsche Bank Reiterates a 'Buy' on CVS Caremark (CVS); Raises PT After Meeting W/ Mgmt
-
Auriga Reiterates a 'Buy' Rating on McKesson (MCK); Raises PT & 2011 Estimates
-
Walgreen (WAG) Surges On Blow-Out Fourth Quarter Results
-
Barron's Article Makes Comments on CVS Caremark (CVS); Discounted Valuation May Vault Shares to $40 Level
-
William Blair Upgrades CVS Caremark (CVS) to Outperform
-
Goldman Sachs Bumps Price Target on CVS Caremark (CVS) to $40
-
Auriga Reiterates a 'Buy' on McKesson (MCK); Adjusts Estimates & Price Target
-
McKesson (MCK) Shares Jump as Analyst Upgrades to Outperform
-
Goldman Sachs Added CVS Caremark (CVS) to its Conviction Buy List
-
Wal-Mart (WMT) Down 6% on Downgrade, Market Sell-Off
-
ARGUS Maintains Buy Rating on Walgreen (WAG), Says Acquisition Offer of Longs (LDG) Out Of Character
-
Walgreen (WAG) at $34 is a Buy -Cramer
-
SunTrust Downgrades Longs Drug Stores (LDG) to Neutral
-
Citi Maintains 'Hold' on AmerisourceBergen (ABC), Sees Higher Risk After CVS Acquisition of Longs Drug Stores
-
BofA Initiates Coverage on CVS Caremark (CVS) with a Buy
-
Jefferies & Co Initiates Coverage on CVS Caremark (CVS) with a Buy
-
S&P Equity Research Reiterates 'Strong Buy' on CVS Caremark (CVS)
-
Piper Jaffray Reiterates Buy on Physicians Formula (FACE); $16 PT
-
Deutsche Bank upgrades Retail/Department Stores to Neutral
-
Citi Raises Food & Staples Retailing to Market-Weight, Adds CVS and ALL to 'Recommended List'
-
Deutsche Bank Adjusts Price Targets on Retailers and Drug Stores
-
UBS resumes coverage on CVS with a Buy; RAD and WAG with Neutrals
-
JP Morgan upgrades CVS Caremark (CVS) to Overweight
-
Leerink Swann Starts CVS Caremark (CVS) at Outperform
-
S&P Equity Research Adds CVS/Caremark (CVS) to Top Ten Portfolio
-
Banc of America resumes coverage on CVS/Caremark (CVS) at Buy
-
FTN Midwest Initiates Coverage on CVS/Caremark (CVS) with a Buy
-
UBS reinstates coverage on CVS (CVS) with a Buy
-
Credit Suisse reinstates coverage on CVS Corp (CVS) at Outperform
-
Deutsche Bank upgrades CVS (CVS) to Buy
-
Merrill Lynch removes CVS Corp (CVS) from Focus 1 List
-
Goldman Sachs Adds CVS to Conviction Buy List
-
Raymond James upgrades CVS Corp (CVS) to Strong Buy
-
Deutsche Bank downgrades CVS (CVS) to Hold
-
CVS Corp (CVS) options active at higher implied volatility on WMT generic program
-
S&P Equity Research Downgrades Cardinal Health (CAH) to Hold
-
Citigroup Initiates Coverage on CVS Corp (CVS) with a Buy
-
Jim Cramer Makes Positive Comments on CVS Corp (CVS)
-
Goldman Sachs adds ARO, CVS, PETM, TGT to Conviction Buy List
-
Goldman Sachs Resumes CVS Corp. (CVS) at Outperform
-
Lehman Brothers Stats (CVS) at Overweight
-
Credit Suisse Adds CVS To Focus List
-
Hearing Banc of America Started WAG and CVS at Buy
-
H&R Block Financial Advisors Highlights Stocks for 2006
-
Merrill Lynch Adds CVS to Focus List
-
Merrill Lynch Adds CVS To Focus List
Back to CVS Stock Lookup
